An investigation was conducted for Mycobacterium avium ss paratuberculosis infections in a research herd of llamas and alpacas. Herd culture-negative status was established over a 23-month period by screening any individuals with any signs compatible with paratuberculosis (n ϭ 1), high serology values (n ϭ 8), or other health and research related reasons (n ϭ 24). There were no M. avium ss paratuberculosis isolates from radiometric cultures of multiple tissue and fecal samples from these individuals and no known sources of exposure. Paratuberculosis is uncommon in North American llamas and alpacas: only 5 cases were identified after an extensive search of the Veterinary Medical Data Base, diagnostic laboratory records, publication databases, and personal communications. Therefore, serum samples from llamas (n ϭ 84) and alpacas (n ϭ 16) in the culture-negative herd were used to obtain preliminary estimates of test specificity for 3 enzyme-linked immunoassays (ELISAs) and an agar gel immunodiffusion (AGID) assay kit for detecting serum antibodies to M. avium ss paratuberculosis in South American camelids. The ELISAs were modifications of established bovine assays for antibody detection. With provisional cutoffs, ELISA-A had 52 false positives (specificity 48%), ELISA-B had 8 false positives (specificity 92%), ELISA-C had two false positives (specificity 98%), and the AGID had 0 false positives (specificity 100%). The range of ELISA values for culture-positive llamas and alpacas (n ϭ 10) from other herds overlapped the range of values for culture-negative llamas and alpacas. The accuracy of the ELISAs may be improved by using age-and sex-specific cutoffs because uninfected male llamas and alpacas that were older than 1 year had higher values for some tests. These tests can be used for either llamas or alpacas; the protein-G conjugate ELISA (ELISA-B) may be useful for multispecies applications. These assays are best used for rapid presumptive diagnoses of llamas and alpacas with diarrhea and weight loss and as a screening tool for herds known to be exposed to infection. All seropositive results should be confirmed with culture.
established in the industry. Because llama and alpaca importations and animal transfers among herds are important to the genetic and economic health of the llama and alpaca industry and because animal movements are the means by which paratuberculosis is spread, the industry requires validated diagnostic tools for identifying infected animals and herds. The long subclinical phase, the potential for few infected animals in a herd to show clinical disease, the challenge of diagnosing early infection, and the organism's persistence in the environment represent significant challenges to prevention and control efforts. 7, 8, 10 The bacterium responsible for paratuberculosis, formerly called Mycobacterium paratuberculosis, was recently renamed Mycobacterium avium ss paratuberculosis. 21 The gold standard for diagnosing paratuberculosis is bacterial isolation of M. a. ss paratuberculosis from feces or tissues. However, the time lag before results are available can be a limitation because conventional and radiometric culture methods require 12-16 weeks 9,22 and 4-8 weeks, 4 respectively. Serology offers the advantage of quick and economical results, although the sensitivity and specificity of these assays for diagnosing paratuberculosis in camelids have not been determined.
The objective of this report is to present preliminary results for 3 enzyme-linked immunoassays (ELISAs) and an agar gel immunodiffusion (AGID) assay for detecting antibodies to M. a. ss paratuberculosis in the serum of llamas and alpacas. The emphasis is to present data that will assist clinicians with the selection and interpretation of serologic assays for paratuberculosis in llamas and alpacas. This study was prompted by serology results from a commercial testing service (ELISA-A) that indicated that llamas and alpacas in a university research herd had antibodies to M. a. ss paratuberculosis. The serology results were inconsistent with the continued absence of M. a. ss paratuberculosis isolations from fecal and tissue samples collected from the herd, the apparent absence of exposure, and the absence of clinical cases. Establishment of culture-negative status for the research herd provided an opportunity to evaluate serologic test specificity in llamas and alpacas for ELISA-A and two additional ELISAs. In addition, results for culture-positive llamas and alpacas from other herds are provided for comparison and to assist with the establishment of provisional cutoffs for the assays.
Materials and methods
The herd investigation included 84 llamas and 16 alpacas in the Oregon State University research herd (OSURH). This herd was established in 1985, and animals are housed in accordance with University Animal Care Protocols with free access to pasture. They are also fed grass hay with a mineral supplement. Animals in this herd and the herds from which they originated had no known history of exposure to M. a. ss paratuberculosis, no clinical cases of paratuberculosis, and no undiagnosed diarrhea or weight loss.
The infection status of animals in this study was established over a 23-mo period by submitting multiple fecal samples, or samples of gastrointestinal tissue and mesenteric lymph node, or both feces and tissue samples for mycobacterial culture. Animals were considered culture negative if their samples failed to yield an isolate of M. a. ss paratuberculosis.
Study animals and sample collection. The first case was a 5-yr-old female alpaca (A) that had serum tested by ELISA-A as part of a diagnostic evaluation of idiopathic intermittent soft stool of 1-yr duration. On the basis of serology results that were classified as positive, surgical biopsies of mesenteric lymph node and ileum were collected from alpaca A and her 19-mo-old daughter (B). 12 Biopsy samples were submitted for histopathology and acid-fast staining to the Oregon State University, Veterinary Diagnostic Laboratory (OSUVDL), for conventional culture with Herrold's egg yolk media (OSUVDL), and for radiometric culture through the University of Wisconsin, School of Veterinary Medicine, Johne's Testing Center (UWJTC). 4 In addition, 1 fecal sample per week was collected for 4 wk from each alpaca and submitted for radiometric mycobacterial cul-ture (UWJTC). Alpaca A's clinical signs subsequently resolved spontaneously.
Although alpaca A was the only animal in the herd with clinical signs consistent with paratuberculosis, diagnostics for paratuberculosis were concurrently conducted on other members of the herd to rule out subclinical infections. Animals were selected for diagnostics on the basis of high ELISA values for available assays (ELISA-A and ELISA-B) or were opportunistically sampled. Animals with the highest serology values in the herd were considered to have a higher risk of infection, as with cattle, 18 and these animals had 3 fecal samples submitted for radiometric culture with collection periods ranging from 4 days to 4 mo to determine infection status. These animals included 5 llamas with at least 1 ELISA-A value Ͼ5.0 (values Ͼ2.0 considered positive) and 3 additional llamas with ELISA-B values classified as positive on the basis of an optical density Ͼ0.237, although their ELISA-A values were Ͻ5.0. These samples represented 5 of 7 llamas and alpacas with the highest ELISA-A values and 7 of 8 animals classified as seropositive by ELISA-B. One of the 7 llamas and alpacas with the highest ELISA-A values was euthanized for reasons unrelated to paratuberculosis, and mesenteric lymph node and intestine were submitted for mycobacterial culture to determine this animal's infection status. A clinically normal 10-mo-old juvenile male alpaca (alpaca C) had ELISA-A values Ͼ5.0 and was seropositive for ELISA-B but was unavailable for collection of feces. Feces were collected for culture from alpaca D (alpaca C's mother and an animal with low serology values) as a proxy for testing alpaca C.
During the course of the investigation, fecal and tissue (small intestine, mesenteric lymph node, mediastinal lymph node) samples were opportunistically collected and submitted for radiometric culture from 11 llamas (2 of which did not have serum submitted for the serologic survey) and 5 alpacas that were euthanized for reasons unrelated to paratuberculosis, as well as from 1 llama and 1 alpaca that died of undetermined causes. In addition, acid-fast stains were performed on small intestine and mesenteric lymph node samples from 3 lamas euthanized for research purposes. Two to four fecal cultures (collected over 7-20 days) were also opportunistically submitted for radiometric culture from an additional 4 llamas and 1 alpaca.
Epidemiology. To supplement our herd investigation strategy, we attempted to identify potential sources of infection for our herd, as well as clarify the epidemiology, pathogenesis, and means of diagnosing paratuberculosis in llamas and alpacas. A search of the Veterinary Medical Data Base (VMDB) of Purdue University, West Lafayette, Indiana, was conducted to identify llamas, alpacas, and guanacos diagnosed with mycobacterial infections, diarrhea, or chronic weight loss at North American Veterinary Teaching Hospitals (NAVMTH) between January 1, 1980 and January 31, 1995. To identify additional cases of paratuberculosis on a national level, National Veterinary Services Laboratory (NVSL) records between October 1, 1980 and July 25, 1995 were searched for llamas and alpacas with mycobacterial culture submissions. To identify potential sources of infection to OSURH within the state, a search of Oregon Department of Agriculture records for llamas and alpacas with paratuberculosis was conducted for submissions between 1981 (inception of the program) thru December 31, 1995. Identification of additional cases was attempted with Medline, Agricola, and Biological Abstracts databases plus personal communications. Case records were obtained and reviewed for each llama and alpaca with M. a. ss paratuberculosis cultured from feces or tissue.
During an early part of the herd investigation, a third group of 16 Oregon llamas not in the OSURH was established for comparison with the OSURH. The ELISA-A and ELISA-B results for these animals were evaluated as part of an assessment of the OSURH's infection status, prior to receipt of tissue and fecal culture results.
Laboratory methods. Samples submitted for conventional culture were cultured on Herrold's egg yolk medium (Whitlock RH, Rosenberger A, Spencer P: 1993, Laboratory culture techniques for Johne's disease: a critical evaluation of contamination and incubation times. Proc Ann Meet US Anim Health Assoc, pp. 382-386). Samples were cultured in triplicate, with 2 cultures supplemented with ferric mycobactin J. a Cultures were observed for 12 wk for slowgrowing mycobacterial colonies. Samples cultured radiometrically were assessed weekly for growth for up to 8 wk. 4 An immobilized protein G b was used to capture the IgG from llama and alpaca sera. Bovine serum was used as a positive control. The relative binding affinities of llama and alpaca IgG for protein G were visualized by Coomassie blue staining of a sodium dodecyl sulfate (SDS) polyacrylamide gel. 19 This procedure provided a qualitative assessment of the equivalence of llama and alpaca serum for these assays for all ELISAs.
Matched serum subsamples were shipped frozen, without indication as to clinical and culture status, to 1) a laboratory with a commercial ELISA testing service for detecting antibodies to M. a. ss paratuberculosis in llama serum (ELISA-A); 2) a second laboratory that modified a different ELISA for detection of antibodies to M. a. ss paratuberculosis in cattle for this study (ELISA-B); and 3) a university-based laboratory that developed a third ELISA (ELISA-C).
The ELISA-A was conducted as described for a bovine Mptb-ELISA assay 18, 23 and was modified by the substitution of an anti-llama conjugate (source; proprietary information) for anti-bovine conjugate. Raw optical density (OD) values were transformed to give scores on a scale of 1-10, and assay interpretation was conducted as described for the bovine assay, 18 with values 1.5-2.0 classified as suspect and Ն2.1 classified as positive. Positive and negative control sera were from the cattle that were culture positive and culture negative, respectively, for M. a. ss paratuberculosis.
The ELISA-B assay was based on a USDA-licensed bovine M. paratuberculosis antibody test kit c and was conducted as described for the bovine assay, 5, 18, 23 with the substitution of the anti-bovine immunoglobulin conjugate with a non-species-specific protein G conjugate. b Results were reported as untransformed OD values, and positive cutoff for the ELISA-B was assumed to be 0.100 OD units greater than the negative control, as for the bovine assay. Positive control serum was from 2 llamas and 2 cattle with tissue culture-confirmed M. a. ss paratuberculosis infections, and negative control serum was from 2 tissue culture-negative cattle.
The ELISA-C was also a modification of the USDA-licensed bovine M. paratuberculosis antibody test kit. c, 5, 18, 23 The ELISA-C used an anti-llama IgG conjugate d instead of the kit's anti-bovine immunoglobulin conjugate. The antillama IgG d was conjugated to horseradish peroxidase (HRP). The assay was then conducted per the bovine protocol with the anti-llama HRP conjugate at its optimal dilution (determined to be 1:8,000). This assay was developed and evaluated after completion of the herd investigation.
Raw OD values for ELISA-C were transformed to ELISA value % (EV%). EV% expresses OD values for each serum sample in relation to the negative and positive controls in order to control for interassay variation. EV% is calculated by dividing the difference of the sample OD and the mean negative control by the difference of the mean negative and positive controls. 3 Results were reported with an EV% scale of 0-100. A llama from a different herd free of clinical paratuberculosis and with mesentric lymph node and small intestine samples that failed to yield M. a. ss paratuberculosis with mycobacterial culture was used as a negative control for the EV% calculations. A pool of serum from 5 tissue culture-positive llamas and alpacas was used as the positive control. The preliminary cutoff for a positive test was an EV% of 20 and was based on the preference for a cutoff that provided a specificity of 98% or greater.
The commercial laboratory performing the ELISA-A also performed AGIDF on all samples with ELISA-A values Ն2.0 (n ϭ 62) and on 2 additional samples with ELISA values of 1.1 and 1.5. The UWJTC used the AGIDF to test 2 culture-positive llama.
Analysis. On the basis of negative mycobacterial culture results and an abscence of sources of exposure, preliminary assay specificities for detecting antibodies to M. a. ss paratuberculosis in llama and alpaca serum were determined with the OSURH (n ϭ 100) as a culture-negative group. Because the specificity of assays varies by the cutoff selected, serum from culture-positive llamas and alpacas from other herds provided a reference for evaluating provisional cutoffs and determining preliminary test sensitivities. Animals were considered culture positive if their samples resulted in the isolation of M. a. ss. paratuberculosis confirmed by a genetic probe for IS900. Culture-positive animals were considered to have clinical infections if weight loss or diarrhea were apparent and subclinical infections if these signs were not apparent. The culture-positive group consisted of 2 North American llamas with clinical paratuberculosis and 8 Australian alpacas, 4 of which had clinical paratuberculosis. Appropriate import permits were obtained for the Australian alpaca samples, and all import restrictions were met. The first 10 infections identified in the outbreak of paratuberculosis in Australian alpacas have previously been reported. 13 Serum samples remaining after assays were conducted were transferred to a serum bank established for paratuberculosis research (UWJTC). 17 As a part of the investigation, statistical analyses were conducted to determine whether adjusting assay cutoffs on the basis of demographic variables could reduce false-positive test results. Each of the 100 OSURH serum samples was tested with each of the 3 ELISA assays, and values for each animal are reported; no outliers are excluded. Some animals had test results from serum samples collected at different times, and serology results from the most recent sample date are reported and are used in statistical procedures. Serology results for the culture-negative OSURH were evaluated with a 2-tailed t-test for differences based on species, age (Ͻ1 yr and Ն1 yr), sex, and herd (OSURH and non-OSURH). Analysis of variance (ANOVA) was used to evaluate serology results on the basis of reproductive status (male, nonpregnant female, pregnant female), and groups with significant differences were identified by Tukey's multiple range test. Regression analysis was used to assess any interaction between age (in months) and reproductive status for assays with ANOVA results indicating significant differences. No statistical analyses were conducted on culture-positive animals because of the small sample size. Statistical calculations were performed with a commercial software program. g
Results
There was no evidence for M. a. ss paratuberculosis infections in the OSURH (n ϭ 100) on the basis of the absence of known sources of exposure for all herd members, the absence of acid-fast organisms and pathology consistent with paratuberculosis in tissue samples from herd members (n ϭ 5), and the absence of isolates in mycobacterial cultures of 127 fecal and tissue samples taken from 33 animals. In the single animal with clinical signs consistent with paratuberculosis, soft stools resolved spontaneously, which would not be expected if the animal was infected with M. a. ss paratuberculosis. In addition, there was no significant difference between OSURH and non-OSURH animals for ELISA-A (P ϭ 0.28) or ELISA-B (P ϭ 0.07). Serum from non-OSURH animals was unavailable for testing with ELISA-C.
The VMDB search did not identify any mycobacterial infection among 76 alpacas examined at NAVMTH. Paratuberculosis was an uncommon diagnosis in llamas at NAVMTH; only 4 llamas were identified by VMDB with culture-confirmed M. a. ss paratuberculosis infections among 3,384 llamas examined (0.12%). Each of these animals had diarrhea and weight loss and comprised 6.2% of all llamas examined for diarrhea (n ϭ 65), 23.5% of all llamas examined for malnutrition (a surrogate for weight loss in this data base; n ϭ 17), and 66.7% of llamas with both malnutrition and diarrhea (n ϭ 6). Two of the llamas previously reported 2 were the only cases identified in the search of databases for published reports and were from a single-species herd. Two of the llamas have not previously been reported (University of Wisconsin, Veterinary Medical Teaching Hospital) and were from a mixed-species herd. A third llama from the mixedspecies herd had weight loss and M. avium was iso-lated from tissues. Personal communications identified an additional llama with diarrhea, weight loss, and M. a. ss paratuberculosis isolated from tissues and identified by DNA probe (South Dakota State University, Animal Disease Research and Diagnostic Laboratory, Brookings, SD; (Genetzky R, Johnson D, Nelson D: 1994, Mycobacterium paratuberculosis in a llama. Proc North Central Association of Veterinary Laboratory Diagnosticians, Manhattan, KS). Mycobacterium a. ss paratuberculosis was isolated from the intestine and mesenteric lymph nodes of the culture-positive animals identified in the VMDB search, with some dissemination to other organs noted. No other llamas or alpaca with paratuberculosis was found by the VMDB search.
The NVSL record search included samples submitted for mycobacterial culture from 73 llamas and 1 alpaca. It was not possible to determine whether any of these cases were seen at NAVMTH. No record of M. a. ss paratuberculosis isolation was found for llamas and alpacas; M. avium was isolated from 3 llamas, M. bovis from 11 llamas, Mycobacterium spp. from 1 llama, and Mycobacterium sp. Runyon Group IV from 3 llamas. A previous search of NVSL records failed to identify any llamas or alpaca for which M. a. ss paratuberculosis was isolated. 20 The Oregon Department of Agriculture, Animal Health Laboratory, did not isolate M. a. ss paratuberculosis from samples from 1 llama and 2 alpacas submitted for mycobacterial culture between 1981 and June 1995, and no culture-positive llama or alpaca was identified at the OSUVDL (R. Sonn, personal communication).
Documenting the absence of M. a. ss paratuberculosis growth in tissue and fecal samples from OSURH animals, in combination with the epidemiological data, provided a unique opportunity for preliminary estimates of ELISA test specificities; each of the 100 OS-URH samples was considered culture negative for analyses. Because of the high number of false-positive results for ELISA-A, it was also important to address whether test specificity could be improved by modifying test cutoffs. As a preliminary means of evaluating provisional ELISA cutoffs, serum from M. a. ss paratuberculosis culture-positive llamas and alpacas from separate herds was assayed to provide a comparison with OSURH animals.
The serology data for llamas and alpacas in the culture-negative OSURH was pooled for all statistical analyses because the relative binding affinities of llama and alpaca IgG for protein G were identical. Pooling results for OSURH llamas and alpacas was further supported by the absence of significant differences between OSURH llamas and alpacas for ELISA-A (P ϭ 0.72), ELISA-B (P ϭ 0.60), and ELISA-C (P ϭ 0.31).
For the culture-negative OSURH, on the basis of the provisional cutoffs for each assay, 52 llamas and alpacas were incorrectly classified as positive for antibodies to M. a. ss paratuberculosis with ELISA-A, 8 llamas and alpacas were false positive with ELISA-B, and 2 llamas and alpacas were false positive with ELISA-C. These false positives provided preliminary estimates of test specificity of 48% for ELISA-A, 92% for ELISA-B, and 98% for ELISA-C. The range of values for culture-negative llamas and alpacas overlapped the range of values for culture-positive llamas and alpacas for ELISA-A and ELISA-C, whereas only 2 culture-positive llamas and alpacas were tested with ELISA-B and there was not an overlap in values ( Fig. 1; Table 1 ). Of the culture-positive llamas and alpacas, each of 10 animals tested was classified as positive with ELISA-A, each of 2 llamas tested was positive with ELISA-B, and 4 of 10 animals tested were positive with ELISA-C ( Table 2) .
The culture-negative OSURH animals Ͻ1 yr old (n ϭ 21) had significantly lower values for ELISA-A (P Ͻ 0.001), ELISA-B (P ϭ 0.05), and ELISA-C (P ϭ 0.007) than did older animals (Fig. 2) . Males (n ϭ 36) had higher values than females (n ϭ 64) for ELISA-A (P ϭ 0.008) and ELISA-B (P ϭ 0.011) but not for ELISA-C (P ϭ 0.852). Further analysis by ANOVA indicated a significant difference among males, nonpregnant females, and pregnant females for ELISA-A (P ϭ 0.004) and ELISA-B (P ϭ 0.03) but not for ELISA-C (P ϭ 0.733) ( Fig. 3) . For ELISA-A and ELISA-B, Tukey's multiple range analysis identified nonpregnant females (n ϭ 40) as having lower values than males (n ϭ 36) but not pregnant females (n ϭ 24). Regression analysis did not indicate that a significant interaction existed between age and reproductive status for ELISA-A (P ϭ 0.65) or ELISA-B (P ϭ 0.66).
All AGID results were negative for OSURH (n ϭ 62). Of 3 culture-positive animals, AGID results were positive for 1 alpaca with clinical signs of infection, negative for another alpaca with clinical signs of infection, and weakly positive for a llama with clinical signs of paratuberculosis.
Discussion
This study was conducted to determine whether llamas and alpacas in OSURH were infected with M. a. ss paratuberculosis. The absence of a history of exposure to M. a. ss paratuberculosis the absence of clinical signs compatible with paratuberculosis, and the failure to isolate M. a. ss paratuberculosis from tissue and fecal samples collected from multiple animals over a 23-month period led us to classify the OSURH as culture-negative for M. a. ss paratuberculosis. Apparent false-positive serology results for paratuberculosis based on culture and clinical signs and a similarity among serology results for the OS-URH and those of llamas and alpacas from other herds in the region led us to investigate the provisional specificity and seropositive cutoffs of 3 ELISAs for M. a. ss paratuberculosis as well as additional issues of clinical concern.
This study confirmed that llama and alpaca IgG are qualitatively similar on the basis of SDS polyacrylamide gel electrophoresis. This equivalence has not previously been reported, although it has often been assumed in clinical settings, and provided justification for pooling llama and alpaca serology results for statistical analysis.
Three ELISAs for detection of antibodies to M. a. ss paratuberculosis in llamas and alpacas were evaluated as a preliminary assessment of the clinical utility of these assays with the culture-negative OSURH and values for culture-positive animals from other herds. ELISA-A had a poor specificity (48%), which would be contraindicated for most clinical applications. Because there was substantial overlap in the values for culture-positive and culture-negative animals for ELISA-A ( Fig. 1) , it is unlikely that modifying the manufacturer's cutoffs would improve the value of this test in a clinical setting. The ELISA-B demonstrated that incorporation of a protein G conjugate may result in an ELISA with good specificity (92%) that can be used on multiple species. Although we could test only 2 culture-positive animals with this assay, our prelim-inary results suggest that ELISA-B may distinguish infected and noninfected animals sufficiently to be of clinical value. The cutoff for ELISA-C was selected for a 98% specificity because of concern for the consequences of false-positive results. This may have compromised test sensitivity because only 4 of 10 culture-positive animals were correctly classified. These results are comparable with results obtained for bovines. Therefore, as with bovines, ELISA-B and ELISA-C may have clinical utility for screening llama and alpaca herds for M. a. ss paratuberculosis, as well as provide prompt, provisional diagnoses of paratuberculosis in llamas and alpacas with clinical disease. Further work is needed to establish optimal serologic cutoffs for each assay.
The association between ELISA serology results and demographic characteristics was evaluated early in the investigation as an exploratory tool to identify potential risk factors for high M. a. ss paratuberculosis serology values. The data were subsequently evaluated to determine whether test specificity could be improved with demographically based serologic cutoffs.
Although we are not aware of reports of age-or sexspecific differences in M. a. ss paratuberculosis serology results for other species, the existence of demographically based cutoffs for other veterinary diagnostic assays suggests that if the higher mean ELISA values for animals Ͼ1 year old ( Fig. 2) and males observed in OSURH (Fig. 3 ) are observed in other herds, demographically based cutoffs would improve the clinical utility of these assays for llamas and alpacas.
The AGID has a preliminary specificity of 100%, although only 1 of 3 culture-positive animals with clinical signs of infection had strong positive results for M. a. ss paratuberculosis antibodies. Because this assay requires substantial volumes of serum, the limited quantities of serum available precluded running the AGID for all culture-positive llamas and alpacas. However, these results are consistent with earlier data 2 that suggest that AGID assays optimized for bovines are not optimized for llamas and alpacas, and negative test results should be accepted with caution. Similar caution should be exercised when applying AGID results optimized for caprines and ovines to paratuberculosis-suspect llamas and alpacas. 6 Preliminary estimates of ELISA specificities showed differences that might be due to assay-related factors, including differences in conjugates, cutoffs, assay execution, positive and negative control sera, method of assay interpretation, and other factors. 8, 14, 18 It is well established that exposure to saprophytic mycobacteria can also compromise test specificity, 23 and it is unclear whether animals in this region of the country have higher exposure to such environmental agents or whether demographically based factors influence exposure rates. Therefore, until results from other herds of known, culture-confirmed infection status in additional geographic regions are available, these results must be regarded as preliminary.
Literature and laboratory database searches, along with personal communications, confirmed that the pathology, clinical course, and epidemiology of M. a. ss paratuberculosis infections in llamas and alpacas are similar to those of ruminants. Literature search identified 2 abstracts 11, 16 concerning a presumptive case of paratuberculosis in a single llama 1 and 2 recent references with cases confirmed by culture. 2, 13 Two additional llama and alpaca herds in North America were identified with unpublished, culture-confirmed M. a. ss paratuberculosis infections. Because most owners are willing to invest in veterinary services for these valuable animals and conventional management practices allow North American llamas and alpacas to live full life spans, unlike conventional management practices for food producing animals, it is unlikely that our search missed many, if any, additional cases of paratuberculosis in North American llamas and alpacas.
Paratuberculosis is infrequently reported in North American llamas and alpacas. The 0.12% prevalence of llamas and alpacas with paratuberculosis diagnosed in North American veterinary medical teaching hospitals probably does not reflect the true prevalence of paratuberculosis among all North American llamas and alpacas. 15 Nevertheless, these data can be used by clinicians to informally estimate provisional test predictive values for the ELISAs.
The design of this study requires that these estimates of test specificity be regarded as preliminary and rough approximations. However, given the high economic and personal value of llamas and alpacas in North America, relative to most ruminants, it is important that information on test accuracy and the prevalence of paratuberculosis in llamas and alpacas be available for clinical applications. When more culture-confirmed cases are identified, evaluation of test sensitivity will need to be done. As with cattle, serologic assays for antibodies to M. a. ss paratuberculosis are best viewed as screening tools for identifying animals and herds with the highest probability of infection. However, the predictive value of these assays may be improved when testing llamas and alpacas with diarrhea and weight loss or when cutoffs are selected to meet specific objectives. 14 As with all tests applied to a new species, testing laboratories need to candidly provide clinicians with information regarding test accuracy. It is important that the diagnosis in all seropositive animals be confirmed by mycobacterial culture of tissues or feces.
